Omeros (OMER) FCF Margin Growth (3y) (2013 - 2022)
Powered by 
Analysis
Omeros (OMER) FCF Margin Growth (3y) (2013 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -3,088.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 14,060.00 |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -13,035.00 |
| Mar 31, 2022 | -15,688.00 |
| Dec 31, 2021 | 5,312.00 |
| Sep 30, 2021 | 72,292.00 |
| Jun 30, 2021 | 178,391.00 |
| Mar 31, 2021 | 53,167.00 |
| Dec 31, 2020 | -14,281.00 |
| Sep 30, 2020 | -8,224.00 |
| Jun 30, 2020 | -22,995.00 |
| Mar 31, 2020 | 6,510.00 |
| Dec 31, 2019 | 1,563.00 |
| Sep 30, 2019 | 7,444.00 |
| Jun 30, 2019 | 6,587.00 |
| Mar 31, 2019 | 16,384.00 |
| Dec 31, 2018 | 13,707.00 |
| Sep 30, 2018 | -35,226.00 |
| Jun 30, 2018 | -135,722.00 |
| Mar 31, 2018 | 378,126.00 |
| Dec 31, 2017 | 869,579.00 |
| Sep 30, 2017 | 740,236.00 |